Skip to Content Skip to Content

Medicine

Reset All Filters
1653 Results
Penn-made AI tool matched a patient’s rare disease with a common inflammation drug. He’s been in remission for over two years

Penn-made AI tool matched a patient’s rare disease with a common inflammation drug. He’s been in remission for over two years

Every Cure, a nonprofit founded by David Fajgenbaum of the Perelman School of Medicine, has received $108 million in federal contracts and private financing to identify promising disease-medication matches and make recommendations for further clinical study.

New mRNA therapy could repair damaged lungs
Rendering of damaged lungs.

Image: iStock/Design Cells

New mRNA therapy could repair damaged lungs

Penn researchers have designed an organ-specific mRNA and lipid nanoparticle therapy which could lead to new targeted treatments for damaged organs.

Alex Gardner

With hemophilia B, a lifetime of worry eased with one infusion
An infusion bag hanging in a hospital room.

Image: iStock/Isaac Lee

With hemophilia B, a lifetime of worry eased with one infusion

The first Penn Medicine patient to receive an FDA-approved new gene therapy for hemophilia B can now stop regular prophylactic clotting factor injections.

From Penn Medicine News

Pursuing vaccines to stop celiac disease
A researcher holding a vaccine vial in a lab next to a microscope.

Image: iStock/nuttapong punna

Pursuing vaccines to stop celiac disease

Scientists at Penn’s Institute for RNA Innovation are using messenger RNA to stop the immune response that triggers celiac disease symptoms.

Alex Gardner

Researchers create genetic map tied to kidney disease
microscopic rendering of DNA strands.

Image: iStock/TanyaJoy

Researchers create genetic map tied to kidney disease

The creation of the most complete map of more than 1,000 genes that influence kidney function could help experts diagnose and design targeted treatments for kidney disease.

Alex Gardner